ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZM Alizyme

4.08
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alizyme LSE:AZM London Ordinary Share GB0000374289
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.08 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Alizyme Share Discussion Threads

Showing 25651 to 25665 of 25975 messages
Chat Pages: Latest  1027  1026  1025  1024  1023  1022  1021  1020  1019  1018  1017  1016  Older
DateSubjectAuthorDiscuss
31/7/2009
17:58
surprise, surprise.
So maybe the shares arn't worthless.

mad mike
31/7/2009
17:27
Since Alizyme plc and Alizyme Therapeutics Limited entered administration on Monday 27 July, the administrators, Ian Carr and Nigel Morrison, partners at Grant Thornton UK LLP, have been approached by a number of parties interested in acquiring certain of the companies' products.
mole16
31/7/2009
14:38
Ur a disgrace VOW.

Dont ever darken any investors door again I say. Give Tim a call and hang out with him.

silverbackalpha
30/7/2009
22:39
No worries Mike, bit worried about what else you have taken me seriously over the years the times I have resorted to the lowest form of humour:-)

Personally I think it was bad manners not to continue with the AGM just to thank the "fans" and help explain some of the blanks in this whole saga instead of running with shirt tails flapping.

vow
30/7/2009
20:28
I was looking forward to being let out yesterday, to attend the AGM, and giving the remainder of the old Board, two barrels.

Funny, how the old Board didn't overrule Tim's guarantee at the last AGM, yet wern't available to face the music yesterday. I would have loved to have made those Board member squirm, and face up to their their uselessness.

Well, at least being a member of the Board, when the company went bust, they will forever have that on their career record.

mad mike
30/7/2009
20:18
You're not locked in a cell are you?


I'm not serious (honest)

romust
30/7/2009
20:14
I honestly didn't see the possible sarcasm first time around!

Maybe it is the cell I'm locked in that is to blame! LOL!

mad mike
30/7/2009
20:11
Sorry mike..but if you can't see the sarcasm oozing out of what you have just pasted and copied, then you need to get out more.
romust
30/7/2009
16:51
Not sure what you are on about. Dunderhead and Vic have concocted this whole conspiracy of me being in cahoots with Tim to swindle everyone.

The fact is I regularly ring the CEO's of every company I invest in as otherwise you don't get a accurate feeling of how things are.

The Interim statement plus my last phone call with him aftwards, in which he dodged the question of a possible funding gap, convinced me to sell up.

Nothing more sinister than that and I was 100% open about it.

vow
30/7/2009
11:39
Tim sends his love and hopes there are no hard feelings.
vow
30/7/2009
11:24
VOW, how is your golfing mate? Some things are difficult to believe, but understandable after the event.
mad mike
30/7/2009
11:23
No, but why do you ask?
mad mike
30/7/2009
10:34
anyone here from london?
merete4
28/7/2009
21:33
EVERYONE HERE SHOULD LOOK AT Surgical Innovations Group Plc (SUN)

Share price is good value at the moment and there is no chance of this going bust making money every yr !!

DYOR

goingforward
28/7/2009
15:27
(Cambridge news) It fair to say that Alan Goodman didn't cover himself in glory at Cenes, but obviously thats not affected his self worth. Perhaps his magic is to make the money disappear.
__________________

IT will be interesting to see who picks up the pieces left over from Alizyme going into administration on Friday.

The Granta Park-based biotech company looked earlier this month as if it had a knight in shining armour riding in to save the day, but serial biotech entrepreneur and investor Alan Goodman has been forced to throw in the towel.

He took over briefly as chairman in a last ditch effort to save the business, which had already warned it would not last without more funds by the end of next month.

At one time Alizyme was seen as a big rising star in the biotech firmament and over the biotech years more than £100m has gone into the company, only 15 months ago a further £10m was raised via a share placing.

Mr Goodman told the News earlier this month as he stepped into the chair:

"I love a challenge. I am looking to do my magic."

But even his magic wand couldn't knock away a surprise hit at the end of last week when US firm Prometheus Labs decided to file a complaint against Alizyme for breach of contract.

Mr Goodman pooh-poohs any breach and says he was in negotiations with Prometheus before the surprise complaint, which, he says, immediately made it impossible to raise more funds for Alizyme.

"It's like getting married and having filed for divorce two days beforehand," he said, referring to the complaint filing, which was actually logged on July 21.

"It would have cost £5m to defend and the company doesn't have £5m," he added. "It was a bolt from the blue.

Mr Goodman agreed that the door was now open to pick up Alizyme's assets cheaply and without any encumbrances such as breach of contract complaints.

"But there's a whole lot more pain to come and the sensible thing to do would have been to negotiate. I thought I could do it, but didn't manage to pull it off."

There are 10 people working for the company, which was founded in 1996 by Andrew Porter, a biotech financial analyst, and Tim McCarthy, who was chief financial officer, and until Mr Goodman took over as chairman and ceo earlier this month, chief executive.

In happier times the company was a winner in the London Stock Exchange TechMark Awards. Drugs have been under development to treat obesity and irritable bowel syndrome.

dr biotech
Chat Pages: Latest  1027  1026  1025  1024  1023  1022  1021  1020  1019  1018  1017  1016  Older

Your Recent History

Delayed Upgrade Clock